February 2009 Volume 5, Issue 2

Volume 5, Issue 2 | February 2009

February 2009

In this Issue

Research & Development

Drug Discovery News Placeholder Image

Pfizer buys Wyeth for $68B

Will cut 800 R&D jobs as company seeks reinvention in face of patent expirations
Drug Discovery News Placeholder Image

Town meets gown in J&J-Vandy deal

Janssen Pharmaceutica and Vanderbilt University forge industry-academia research partnership
Drug Discovery News Placeholder Image

Healing the wounded

OmegaGenesis, Mayo Clinic to develop nanomaterials for angiogenesis applications
Drug Discovery News Placeholder Image

Is nanotechnology safe?

U.S. lawmakers address need for more risk research, oversight
Drug Discovery News Placeholder Image

PPD acquires Merck’s 130,000 square-foot vaccine lab

PPD Inc. recently entered a strategic collaboration with Merck & Co. Inc. whereby it acquired the latter’s vaccine testing lab in Wayne, Pa.
Drug Discovery News Placeholder Image

Roche lines up at Synta’s CRACM gate

Billion-dollar alliance to produce oral agents for arthritis, inflammatory diseases

Global News

Drug Discovery News Placeholder Image

Out-of-pocket expense

Lilly pays $1.4 billion to end Zyprexa probe, with cash earmarked for settlement
Drug Discovery News Placeholder Image

Of (bio)similar interests

Teva and Lonza seek to capture a large chunk of the emerging biosimilars market
Drug Discovery News Placeholder Image

Playing hard to get

EXACT Sciences rejects $41 million acquisition offer, and Sequenom refuses to give chase
Drug Discovery News Placeholder Image

Warding off MS

Apitope and Merck Serono to advance MS vaccine
Drug Discovery News Placeholder Image

Out of failure, opportunity

The Medicines Company acquires Targanta for $42M

Genomics & Proteomics

Drug Discovery News Placeholder Image

Running interferon

Bristol-Myers Squibb, ZymoGenetics PEG-Interferon lambda deal could be worth $1 billion
Drug Discovery News Placeholder Image

Breathing new life into pipeline

Alnylam and Cubist enter into partnership to develop RNAi therapeutics for respiratory syncytial virus infection
Drug Discovery News Placeholder Image

They’re locked and loaded

RNA deal with Wyeth could mean as much as $847 million to Santaris even before royalties
Drug Discovery News Placeholder Image

Cardio candidates

Mutant gene puts South Asians at much higher risk of heart disease
Drug Discovery News Placeholder Image

NCI planning to look far and (genome) wide

Agency plans to award up to $96 million for multicenter genome-wide association studies

Automation & Instrumentation

Drug Discovery News Placeholder Image

Culture for growth

Hamilton, GCS collaboration yields high-density cell culture product
Drug Discovery News Placeholder Image

‘Simple but elegant’ system

UT Southwestern Medical Center to use WaferGen’s SmartChip system to identify gene expression biomarkers involved in wound healing
Drug Discovery News Placeholder Image

Test tube trials

VistaGen, Capsant merge stem cells, cell culture and measurement tools for new screening platform
Drug Discovery News Placeholder Image

A sign of the times?

LabAutomation 2009 doesn’t skip a beat with strong year-opening event
Drug Discovery News Placeholder Image

BioTrove, Cisbio enter screening services distribution deal

Companies will combine Cisbio’s HTRF with BioTrove’s RapidFire mass spec platform

Editor's Focus

Drug Discovery News Placeholder Image

Does anyone know what 2009 holds?

Heading for LabAutomation 2009 in Palm Springs, I was sure I would get a pulse on what folks in the industry felt about the financial crisis. But if I went with plenty of questions, I probably came back with a whole bunch more.

Patent News

Drug Discovery News Placeholder Image

Bayer sues Abbott over Humira; Abbott thanks them with their own lawsuit

Last month, Abbott Laboratories was sued by Bayer AG’s HealthCare unit, alleging that Abbott's best-selling drug Humira infringes on a Bayer patent. In one new twist, Abbott has sued Bayer AG’s HealthCare unit, claiming the Bayer patent is invalid, not infringed or unenforceable.

Informatics

Drug Discovery News Placeholder Image

Image is everything

PerkinElmer and IDBS aim to ease high-content screening analysis burdens with Columbus-ActivityBase integration
Drug Discovery News Placeholder Image

The release of FireFly

Prosolio and Indigo BioSystems create data conversion software for mass spec users
Drug Discovery News Placeholder Image

Delving downstream

Ariadne integrates Pathway Studio with Illumina’s GenomeStudio software
Drug Discovery News Placeholder Image

FDA e-data review in next Phase Forward

FDA extends use of Phase Forward’s WebSDM software in submission and review of electronic CDISC format data
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

GreenCooling

Thermo Scientific™ Centrifuges with GreenCool Technology

Next-generation natural refrigerant cooling system for centrifuges, offering a lower Global Warming Potential and reduced energy consumption.
Clear sample tubes are shown in a clear tote with red lids in a sample prep robot with a blue and silver industrial lab background.

The crucial role of sample preparation in biotherapy manufacturing

Discover how better sample preparation can unlock improved assay accuracy and analytical results.
A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue